Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. NV BioHistory (TM)
Career
Job Search Post a Job Destination NV
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
 
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad: American Red Cross, Together, we can save a life
Advertising
 
Jobs
 

ORCA Monthly Meeting: March 16 - Requirements & Best Practices for Management Review

Conference on Biosimilars, University of Washington, Seattle - March 19-20. Sign up today!



BioHistory Moment: Iditarod Trail used to transport diphtheria serum to Nome.

Balto

In 1925, a life-or-death race to save the children of Nome from a diphtheria epidemic made an international hero of one sled dog, and led to the creation of Alaska's Iditarod sled dog race. A diphtheria epidemic threatened remotely located Nome, and air transportation was unavailable to transport serum from Anchorage nearly a thousand miles away.

The solution: A relay of dog teams transported serum on the Iditarod Trail from Nenana to Nome, and every village enroute provided its best team and driver for the next leg continually moving the serum toward Nome. Gunnar Kaasen, a Norwegian musher, drove the final two legs into Nome behind his lead dog Balto through a blizzard with 80 mph winds to deliver 300,000 units of diphtheria antitoxin to Dr. Curtis Welch, the only doctor in Nome.

The serum arrived in time, prevented the epidemic and saved hundreds of lives. The 20 mushers had covered nearly 700 miles in slightly more than 127 hours in temperatures of minus40° Fahrenheit below zero and strong winds. The serum run received worldwide press coverage and the mushers received special gold medals and other recognition. In 1926, a statue of Balto, the heroic lead dog, was erected in New York's Central Park.

More...

Learn about Sacramento's Embarcadero Road Biotech/Medical Device Facility

890 Embarcadero Road, West Sacramento, CA. The Embarcadero Road biotech/medical device facility, located just off Riverside Parkway and Interstate 80, ecompasses 425,146 square feet on 9.76 Acres. This unique facility offers office, laboratory, manufacturing, and assembly space, plus cleanrooms to address your every need. This facility is located in a state designated Enterprise Zone, and the West Sacrament Redevelopment Area/Targeted Employment Zone providing additional incentives and benefits for your company.

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Nevada, regionally or nationwide.

More...

(Advertising)


Industry News...

    Free News Release Posting & Archiving Service


  • Scientists discover causative genetic mutation associated with neurologic disorder  Scientists using advanced genomic analysis technologies from Life Technologies have sequenced an individual's genome and identified the specific causative mutation associated with Charcot-Marie-Tooth Disease (CMT).
    Life Technologies Corporation  March 10, 2010  


  • Monsanto ranks no. 28 on the 2010 DiversityInc Top 50 Companies for Diversity(R) list  Monsanto Company has been named to The 2010 DiversityInc Top 50 Companies for Diversity(R) list for its demonstrated use of measurable diversity best practices and results. A total of 449 companies participated this year, up 12 percent from last year.
    Monsanto Company  March 10, 2010  


  • Vermillion announces Scientific Advisory Board appointments  Vermillion announced the appointment of its distinguished Scientific Advisory Board to assist in directing the Company's product development strategies.
    Vermillion, Inc.  March 10, 2010  


  • Affymax(R) receives $5 million milestone payment on initiation of Phase 3 clinical trials  Affymax announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical as part of the companies' exclusive global agreement to develop and commercialize Hematide(TM), Affymax's investigational drug for the treatment of anemia in chronic renal failure patients.
    Affymax, Inc.  March 10, 2010  


  • Medicis increases cash dividend to $0.06 per share  Medicis announced that its Board of Directors declared a quarter-end cash dividend of $0.06 per issued and outstanding share of its Common Stock payable on April 30, 2010, to stockholders of record at the close of business on April 1, 2010.
    Medicis  March 10, 2010  


More... | Submit News Release | Advertising...

News

New Job Postings...

Free Job Posting Trial Offer
  • Scientist/Senior Scientist, Formulations Seattle Genetics, Inc. (WA)
  • Quality Assurance Validation Associate Seattle Genetics, Inc. (WA)
  • Quality Assurance Manufacturing Associate Seattle Genetics, Inc. (WA)
  • CMC Associate Project Manager Seattle Genetics, Inc. (WA)
  • Drug Safety Specialist Seattle Genetics, Inc. (WA)
More... | Job Advertising... | About Job Postings...
ESL Speaking

New Facilities Available...

ATC clean room constructors...validation guaranteed!
  • 890 Embarcadero Road Property -- West Sacramento, CA
  • CompleGen Lab/Office Space -- Seattle, WA
  • Life Sciences Incubator -- Seattle, WA
  • University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
  • University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA
More... | Facility Advertising...
Facilities

Upcoming Events...

  • 03/11/2010: BayBio NEST Venture Spotlight Series: Heart Matters
  • 03/11/2010: Bagels at BIOCOM
  • 03/11/2010: Online Webinar: Performing Investigations for Environment
  • 03/11/2010: Online Webinar: Environmental Excursion Investigations
  • 03/15/2010: Pharmacovigilance
More... | Submit Event | Event Advertising...
Master's Degree in Biomedical Regulatory Affairs

Learn About Nevada's BioHistory

Learn About Nevada's BioHistory Why is there a life science industry in Nevada? Is the industry growing? What do other states have?

Through Nevada BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in Nevada.

More...

BioEvolution Posters

WA BioEvolution 2008 Poster

More More...


March 10 - National Women and Girls HIV/AIDS Awareness Day

National Women and Girls HIV/AIDS Awareness Day

National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) is a nationwide initiative celebrated on March 10 every year to raise awareness of the increasing impact of HIV/AIDS on women and girls.

Every 35 minutes, a woman tests positive for HIV in the United States. More and more women have become infected with HIV since it was first reported in the early 1980s. Today, about 1 in 4 Americans living with HIV are women. It’s time for women to get tested.

More...


BioFact

(1830) - Proteins discovered.


It's a Small World

  Swine Flu  Virus Swine Flu Virus  

Science Quote

"Science is what you know. Philosophy is what you don't know."

-  Bertrand Russell, English philosopher
 (1872-1970)

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2010 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

NevadaLifeSciences.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of Nevada.